# DynamX Sirolimus Study Sirolimus Eluting Coronary Bioadaptor System

> **NCT03634020** · NA · COMPLETED · sponsor: **Elixir Medical Corporation** · enrollment: 44 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** DynamX Sirolimus-eluting Coronary Bioadaptor System

## Key facts

- **NCT ID:** NCT03634020
- **Lead sponsor:** Elixir Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-10
- **Primary completion:** 2021-03-08
- **Final completion:** 2021-03-08
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2021-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03634020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03634020, "DynamX Sirolimus Study Sirolimus Eluting Coronary Bioadaptor System". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT03634020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*